One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
Dietger Niederwieser(Leipzig University of Applied Sciences), Wael Saber(Medical College of Wisconsin), Jakob Passweg(University Hospital of Basel), Naeem Chaudhri(King Faisal Specialist Hospital & Research Centre), Nina Worel(Medical University of Vienna), Helen Baldomero(University Hospital of Basel), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Jeff Szer(The Royal Melbourne Hospital), Alok Srivastava(M.J.P. Rohilkhand University), Juliana Martínez-Rolón(Latin American and Caribbean Society of Medical Oncology), Mickey Koh(St George's Hospital), Kristjan Paulson(CancerCare Manitoba), Shahrukh K. Hashmi(Mayo Clinic), Alaa Elhaddad(Cairo University), Yoshiko Atsuta(The Japanese Data Center for Hematopoietic Cell Transplantation), Adriana Seber(Support group for adolescents and children with cancer), Amir Ali Hamidieh(Stem Cell Technology Research Center), Caitrin Bupp(National Marrow Donor Program), Gregorio Jaimovich(Favaloro Foundation), Daniel J. Weisdorf(University of Minnesota), Sebastián Galeano(Hospital Británico), Selim Corbacioglu(Unknown), Aloysius Ho(SingHealth), Régis Peffault de Latour(Hôpital Saint-Louis), Nada Hamad(UNSW Sydney), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Jong Wook Lee(The Catholic University of Korea Seoul St. Mary's Hospital), Marcelo C. Pasquini(Cleveland Clinic), Amado Karduss(Instituto de Cancerología Las Américas), Mary M. Horowitz(Medical College of Wisconsin), Cristóbal Frutos(Lithuanian Social Research Centre), Hildegard Greinix(Medical University of Graz), Nosa Bazuaye(Yahoo (Spain)), Nicolaus Kröger(Universität Hamburg), Yoshihisa Kodera(Aichi Medical University), Minako Iida(Aichi Medical University)
Cited by 236
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k